Michaela Scherr
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biological Psychiatry top 5%
Papers in
- Hematology 28
- Chronic Myeloid Leukemia Treatments 17
- Acute Myeloid Leukemia Research 14
-
- MicroRNA in disease regulation 15
- Co-authors
- Matthias Eder (51 shared papers)Karin Battmer (29 shared papers)Arnold Ganser (38 shared papers)Letizia Venturini (20 shared papers)Manuel Grez (9 shared papers)Denise Hilfiker‐Kleiner (26 shared papers)Karl Welte (6 shared papers)Julia Skokowa (5 shared papers)
- Journals
- Blood (15 papers)Leukemia (9 papers)PLoS ONE (8 papers)Gene Therapy (5 papers)Cardiovascular Research (5 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michaela Scherr
117 papers receiving 6.0k citations
Michaela Scherr's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 1.1k
- Biological Psychiatry 151
- Neurology 477
- Hematology 639
- Molecular Biology 3.2k
Countries citing papers authored by Michaela Scherr
This map shows the geographic impact of Michaela Scherr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Scherr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Scherr more than expected).
Fields of papers citing papers by Michaela Scherr
This network shows the impact of papers produced by Michaela Scherr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Scherr. The network helps show where Michaela Scherr may publish in the future.
Co-authors
The 25 scholars most cited alongside Michaela Scherr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia Hit paper breakdown → | 2006 | 1018 |
| 2 | 2002 | 426 | |
| 3 | MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy Hit paper breakdown → | 2013 | 426 |
| 4 | 2007 | 295 | |
| 5 | 2003 | 216 | |
| 6 | 2006 | 175 | |
| 7 | 2007 | 168 | |
| 8 | 2010 | 144 | |
| 9 | 2003 | 132 | |
| 10 | 2010 | 116 | |
| 11 | 2005 | 111 | |
| 12 | 2016 | 100 | |
| 13 | 2007 | 91 | |
| 14 | 2005 | 90 | |
| 15 | 2019 | 85 | |
| 16 | 2011 | 83 | |
| 17 | 2014 | 80 | |
| 18 | 2003 | 78 | |
| 19 | 2000 | 75 | |
| 20 | 1998 | 74 |
About Michaela Scherr
Michaela Scherr is a scholar working on Hematology, Cancer Research, Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology, having authored 118 papers that have together received 6.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (28 papers), Chronic Myeloid Leukemia Treatments (17 papers), Advanced biosensing and bioanalysis techniques (15 papers), MicroRNA in disease regulation (15 papers), Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (13 papers), Virus-based gene therapy research (12 papers) and Cardiovascular Issues in Pregnancy (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Biological Psychiatry (151 citations), Neurology (477 citations), Hematology (639 citations) and Molecular Biology (3.2k citations). Michaela Scherr has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Matthias Eder, Karin Battmer, Arnold Ganser, Letizia Venturini, Manuel Grez, Denise Hilfiker‐Kleiner, Karl Welte, Julia Skokowa, Axel Schambach and Murat Uenalan. Their work appears in journals such as Blood, Leukemia, PLoS ONE, Gene Therapy and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.